Eckert+Ziegler: Independence gains value - NuWays AG Research
Recent radiopharma transactions highlight the strategic value of EUZ’s independent isotope supply and specialist manufacturing, reinforcing our view that its shares are undervalued.
ANNONS
Recent radiopharma transactions highlight the strategic value of EUZ’s independent isotope supply and specialist manufacturing, reinforcing our view that its shares are undervalued.
